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Background: Osteoarthritis (OA) of the hip and knee are among the most common chronic conditions, resulting in
substantial pain and functional limitations. Adequate management of OA requires a combination of medical and
behavioral strategies. However, some recommended therapies are under-utilized in clinical settings, and the
majority of patients with hip and knee OA are overweight and physically inactive. Consequently, interventions at the
provider-level and patient-level both have potential for improving outcomes. This manuscript describes two
ongoing randomized clinical trials being conducted in two different health care systems, examining patient-based
and provider-based interventions for managing hip and knee OA in primary care.
Methods / Design: One study is being conducted within the Department of Veterans Affairs (VA) health care
system and will compare a Combined Patient and Provider intervention relative to usual care among n= 300
patients (10 from each of 30 primary care providers). Another study is being conducted within the Duke Primary
Care Research Consortium and will compare Patient Only, Provider Only, and Combined (Patient + Provider)
interventions relative to usual care among n= 560 patients across 10 clinics. Participants in these studies have
clinical and / or radiographic evidence of hip or knee osteoarthritis, are overweight, and do not meet current
physical activity guidelines. The 12-month, telephone-based patient intervention focuses on physical activity, weight
management, and cognitive behavioral pain management. The provider intervention involves provision of patient-
specific recommendations for care (e.g., referral to physical therapy, knee brace, joint injection), based on evidence-
based guidelines. Outcomes are collected at baseline, 6-months, and 12-months. The primary outcome is the
Western Ontario and McMasters Universities Osteoarthritis Index (self-reported pain, stiffness, and function), and
secondary outcomes are the Short Physical Performance Test Protocol (objective physical function) and the Patient
Health Questionnaire-8 (depressive symptoms). Cost effectiveness of the interventions will also be assessed.
Discussion: Results of these two studies will further our understanding of the most effective strategies for
improving hip and knee OA outcomes in primary care settings.
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Osteoarthritis (OA) is one of the most common chronic
health conditions and a leading cause of pain and disability
among adults [1-3]. The hip and knee are two commonly
affected joints [4,5], having a significant impact on walking
and other daily activities. The prevalence of OA is on the
rise, and this trend is expected to continue [6]. For ex-
ample, recent data from the Framingham Osteoarthritis
Study show that over about the past 20 years, the preva-
lence of knee OA approximately tripled in men and almost
doubled in women [7]. Therefore, in addition to the sub-
stantial toll of OA at the individual level [8], this health
problem has a significant societal impact due to health
care costs [9,10].
Evidence-based guidelines emphasize that adequate man-
agement of hip and knee OA requires a combination of be-
havioral and medical strategies [11-14]. Physical activity
and weight management are two key behavioral strategies
for managing hip and knee OA, supported by numerous
clinical trials and emphasized in treatment guidelines.
However, the majority of adults with OA are physically in-
active and / or overweight. For example, among patients
with knee OA in the Osteoarthritis Initiative, only about
13% of men and 8% of women met the 2008 Department
of Health and Human Services Physical Activity Guidelines
regarding aerobic activity [15]. Data from the Centers for
Disease Control and Prevention show that 66% of US
adults with arthritis (primarily OA) are overweight or obese
[16]. These data clearly show that efforts are needed to im-
prove physical activity and healthy eating behaviors among
individuals with OA. Cognitive behavioral approaches to
pain management can also improve outcomes among
patients with OA [17], but programs to teach these skills
are also not widely accessible to patients.
Although there is a strong evidence base for many
clinical strategies for managing OA (e.g., joint injections,
physical therapy, pain medications), some of these treat-
ments are under-utilized. Several studies have shown low
“pass rates” for quality indicators of care for OA, includ-
ing assessment of pain and function, referrals to other
providers (when indicated), appropriate prescribing of
pain medications, and recommendations for exercise and
weight management [18-20]. Only a few studies have
examined provider-based interventions to enhance man-
agement of OA in clinic settings [21-23]. These studies
have shown improvements in OA treatment practices
and some patient outcomes following the provider inter-
ventions. However, these programs were time-intensive
(making them infeasible in most real-world clinical set-
tings) and only reached a small number of providers.
There is still a need to develop and test provider-based
interventions that can be practically disseminated in
real-world clinical settings to help facilitate improve-
ments in care for patients with OA.This manuscript describes two ongoing clinical trials
in two different health care systems that are examining
patient-based and provider-based interventions for man-
aging hip and knee OA in primary care. The patient-
based intervention focuses on physical activity, weight
management, and cognitive behavioral pain manage-
ment, and the provider intervention involves provision of
patient-specific recommendations for care, based on evi-
dence-based guidelines. Through these two studies, we
are able to evaluate these interventions in distinctly dif-
ferent health care settings and patient populations. One
study is being conducted within the Department of
Veterans Affairs (VA) health care system and will com-
pare a combined patient-based and provider-based inter-
vention relative to usual care. Another study is being
conducted within the Duke Primary Care Research Con-
sortium and will compare patient-based, provider-based,
and combination (patient + provider) interventions rela-
tive to usual care. We are reporting the methods for
these two trials together because they involve common
interventions and measures; design issues that differ be-
tween the studies are specified when appropriate.
Hypotheses
Hypotheses for the VA-based study (reflecting a 2-arm trial)
are:
Primary
H1: Patients with hip and/or knee OA who receive a
comprehensive intervention (including both patient-
based and provider-based components) will have a
larger, clinically relevant improvement in self-reported
pain, stiffness and function, as measured by the Western
Ontario and McMasters Universities Osteoarthritis
Index (WOMAC), compared with usual care.
Secondary
H2: The comprehensive OA intervention will result in
improvement in objectively assessed physical function
(using the Short Physical Performance Test Protocol)
when compared to usual care.
H3: The comprehensive OA intervention will result in
improvement in depressive symptoms (measured with
the Patient Health Questionnaire-8 (PHQ-8) [24])
when compared to usual care.
Hypotheses for the Duke-based study (reflecting a 4-arm
trial) are:
Primary
H1: Compared to usual care, patients with hip and/or knee
OA who receive a combined patient-based and provider-
based intervention will have a larger improvement in self-
reported pain, stiffness and function, as measured by the
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intervention alone.
H2: Patients with hip and/or knee OA who receive
either the patient-based OR provider-based intervention
will have clinically relevant improvements in WOMAC
scores when compared to usual care.
Secondary
H3: The patient-based, provider-based, and combined
interventions will each result in improvement in
objectively assessed physical function (using the Short
Physical Performance Test Protocol) when compared
to usual care, and the combined intervention will
result in the greatest improvement.
H4: The patient-based, provider-based, and combined
interventions will each result in improvement in
depressive symptoms (measured with the PHQ-8 [24])
when compared to usual care, and the combined
intervention will result in the greatest improvement.
Methods / Design
Trial design
Both the VA-based and Duke-based studies are rando-
mized controlled trials, but the study designs differ due to
variations in the arms being tested. The VA-based study is
a cluster randomized controlled trial, in which Primary
Care Providers (PCPs) are assigned to one of two study
arms: OA Intervention and Usual Care Control. PCPs
assigned to the OA Intervention receive the Provider
Intervention described below, and their enrolled patients
receive the Patient Intervention, also described below.
Figure 1 shows the design of the Duke-based trial, in
which clinics are randomized to Provider Intervention
vs. Control, then patients within those clinics are
assigned to Patient Intervention vs. Control. This results
in patients being assigned to one of four study arms: 1.)
Patient Intervention Only, 2.) Provider Intervention
Only, 3.) Patient Intervention + Provider Intervention
and, 4.) Usual Care Control. For both VA and Duke stud-
ies, all participants continue with any other usual med-
ical care they receive for OA. After completion of
follow-up assessments, participants assigned to the Pa-
tient Control condition are given the materials for theRandomize Clinics
Provider Intervention 
Clinics 
Provider Control Clinics 
Patient  
Intervention   
Patient  
Control   
Patient  
Intervention   
Patient  
Control   
Figure 1 Duke study design.Patient Intervention, and clinics / PCPs who were
assigned to the Provider Control condition are given the
patient-specific recommendations for the Provider Inter-
vention. These studies were reviewed and approved by
the Durham VA Medical Center and Duke Institutional
Review Boards, respectively.
Study settings
The VA-based study is being conducted among patients at
the Durham VA Medical Center and its associated com-
munity-based outpatient clinics. The Durham VA Medical
Center serves about 53,600 veterans, about 68% of whom
are age 55 or older and therefore in the prime age category
for the development of OA. The Duke-based study is being
conducted within the Duke Primary Care Research Con-
sortium, a primary care-based research network composed
of 30 practices in 8 counties of the Piedmont area of North
Carolina (both urban and rural).
Participants
Both patients and PCPs serve as participants in these
studies. In the VA-based study, we are enrolling approxi-
mately 30 PCPs and 10 patients (5 white, 5 non-white)
per PCP, for a total sample size of n = 300. In the Duke-
based study, we are enrolling PCPs from 10 PCRC clinics
and approximately 56 patients per clinic, for a total sam-
ple size of n = 560.
All participants must have hip OA (based on radio-
graphic evidence in the electronic medical record) and /
or knee OA (based on radiographic evidence in the elec-
tronic medical record OR meeting American College of
Rheumatology clinical criteria [25]). Participants must
also have current symptoms in the joint(s) with OA. Spe-
cifically, participants must answer “yes” to two questions:
“In the past 12 months, have you had pain, aching, stiff-
ness, or swelling in or around a hip or knee joint with
arthritis?” and “Were these symptoms present on most
days for the past month?” [26]. Because the Patient Inter-
vention for this study focuses on weight management
and physical activity, participants must also be over-
weight (body mass index (BMI) ≥ 25) and not currently
meeting weekly physical activity guidelines set forth by
the Departments of Health and Human Services (2 hours
and 30 minutes of moderate intensity or 1 hour and 15
minutes of vigorous intensity aerobic activity plus 2 or
more sessions of muscle strengthening exercises) [27].
Exclusion criteria for the study are:
 Rheumatoid arthritis, fibromyalgia, or other systemic
rheumatic disease
 History of gout in knee or hip
 Total joint replacement (knee or hip) surgery, other
knee or hip surgery, meniscus tear, or ACL tear in
the past 6 months
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 Hospitalized for a stroke, myocardial infarction,
heart failure, or coronary artery revascularization in
the past 3 months
 Motor neuron diseases, Parkinson’s disease, multiple
sclerosis, Paget’s disease
 Quadriplegic or paraplegic
 Dementia or other memory loss condition
 Metastatic cancer
 Referral for Hospice or Palliative Care
 Nursing home resident
 Active diagnosis of psychosis
 Serious personality disorder
 Current, uncontrolled substance abuse disorder
 Severely impaired hearing or speech (patients must
be able to respond to phone calls)
 Blindness
 No access to a telephone
 Inability to understand or speak English
 Participating in another OA intervention or other
lifestyle change study
 Females: currently pregnant or planning to become
pregnant
 Have not seen PCP in the past 12 months (VA) or
18 months (Duke)
 Other health condition or personal issue judged by a
study team member or primary care physician to
make the patient inappropriate for study
participation
 Other self-reported medical problem that would
prohibit participation in the study
Recruitment and enrollment
Recruitment and enrollment procedures are very similar
for the VA-based and Duke-based studies. We first iden-
tify patients of participating PCPs / clinics who have
diagnoses of hip and / or knee OA, based on relevant
ICD-9 codes from electronic medical records (including
715.00, 715.09, 715.10, 715.15, 715.16, 715.25, 715.26,
715.30, 715.35, 715.36, 715.80, 715.89, 715.90, 715.95,
715.96, 719.40, 719.45, 719.46, 719.49). We then further
examine the medical record to confirm the presence of
an OA diagnosis and scan for exclusion criteria. We mail
introductory letters to patients who meet criteria based
on electronic medical records, on behalf of their PCP.
This is followed about 1–2 weeks later by a screening
telephone call to further assess eligibility, with particular
focus on criteria that may not appear in the electronic
medical record. Eligible, interested patients are asked to
meet a study team member at the clinic site to complete
the consent process and baseline questionnaires. Imme-
diately following the consent process, we assess clinical
criteria for knee OA [25], measure height and weight to
determine BMI, and administer several questions aboutpain and physical function. If patients are not overweight
according to BMI criteria, do not meet clinical criteria
for knee OA (and also do not have radiographic evidence
of hip or knee OA in at least one joint), or do not meet
pain criteria, they are excluded from the study. Following
the initial visit, participants are asked to complete a Food
Frequency Questionnaire (FFQ) at home and return it via
mail within one week. Participants are called with their
randomization assignment once the FFQ has been received
by the study team (or after about 2 weeks if it has not been
returned and is therefore considered missing data).
Randomization
Randomization for both studies is based on a computer
generated sequence maintained by the project statisti-
cian. For the VA-based study, we stratify randomization
of providers according to high vs. low volume of female
patients (<15% vs. ≥15%), to ensure the groups are
balanced in this respect. For the Duke-based study,
clinics are randomized in pairs that are selected based
on common characteristics such as approximate patient
panel size and PC specialty (Family Medicine vs. Internal
Medicine). For both studies, patient randomization is
stratified according to race (white / non-white), and the
Duke-based study is also stratified by patient gender.
This is important because there are known differences in
OA-related pain and function according to both gender
and race, and it is possible that intervention effects may
differ across these demographic variables as well.
Interventions
Patient behavioral intervention for OA
This is a twelve-month intervention that includes the fol-
lowing elements: monthly telephone calls by a counselor
to support behavior change, written patient educational
materials, an exercise video for patients with OA, and a
CD of relaxation exercises (each described below). This
intervention is grounded in social cognitive theory, fo-
cusing on five determinants of health behavior change:
self efficacy, knowledge of health risks and practices, out-
come expectations regarding the costs and benefits of
health behaviors, health goals, and addressing perceived
barriers and facilitators of health [28].
Telephone Calls Telephone calls are the core compo-
nent of this intervention. Individuals with training in
counseling and / or health education and behavior
change deliver this intervention, with oversight provided
by study co-investigators who have experience in each
substantive aspect of the program (e.g., physical activity,
weight management, and cognitive behavioral strategies).
A summary of activities for all calls is shown in Table 1.
Calls are scheduled twice per month for the first six
months, then monthly for the last six months. During
Table 1 Summary of activities for patient intervention calls
Month # Call # Activities / Modules
1 1 - Introduction to Intervention and Materials
- Introduction to Osteoarthritis
- Information Session #1 for Physical Activity
or Healthy Eating (Participant Choice)
- Cognitive or Behavioral Strategy – Activity
Pacing Discussion #1
- Goal Setting
2 - Goal Review
2 1 - Information Session #2 for Physical Activity
or Healthy Eating
- Cognitive or Behavioral Strategy – Activity
Pacing Discussion #2
- Goal Setting
2 - Goal Review
3 1 - Information Session #3 for Physical Activity
or Healthy Eating
- Cognitive or Behavioral Strategy – Breathing
Relaxation Discussion #1
- Goal Setting
2 - Goal Review
4 1 - Information Session #1 for Physical Activity or
Healthy Eating (Whichever not discussed in
months 1–3)
- Cognitive or Behavioral Strategy – Breathing
Relaxation Discussion #2
- Goal Setting
2 - Goal Review
5 1 - Information Session #2 for Physical Activity or
Healthy Eating
- Cognitive or Behavioral Strategy – Distraction
Discussion #1
- Goal Setting
2 - Goal Review
6 1 - Information Session #2 for Physical Activity or
Healthy Eating
- Cognitive or Behavioral Strategy – Distraction
Discussion #2
- Goal Setting
2 - Goal Review
7 1 - Cognitive or Behavioral Strategy – Progressive
Muscle Relaxation Discussion #1
- Goal Setting
8 1 - Cognitive or Behavioral Strategy – Progressive
Muscle Relaxation Discussion #2
- Goal Setting
9 1 - Cognitive or Behavioral Strategy – Cognitive
Restructuring Discussion #1
- Goal Setting
10 1 - Cognitive or Behavioral Strategy – Cognitive
Restructuring Discussion #2
- Goal Setting
Table 1 Summary of activities for patient intervention calls
(Continued)
11 1 - Make-Up or Review
- Goal Setting
12 1 - Make-Up or Review
- Goal Setting
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call (e.g., new educational information is reviewed), and
the second call is used to review participants’ progress
toward goals. All calls use standardized scripts to assist
with consistency of information delivery.
During the first three months of the study, participants
are asked to choose whether to focus on either weight
management or physical activity. Both the educational
content and the goal-setting focus on that topic. At the
first call for each of the first three months, the counse-
lors provide a summary of key points that will be cov-
ered related to physical activity or weight management
content (listed below).
Physical activity
Month 1: General Information about Physical Activity
and OA & Aerobic Activity; Managing Pain with Physical
Activity
Month 2: Stretching Exercises; General Tips for Success
with Physical Activity
Month 3: Strengthening Exercises
Weight management
Month 1: Setting a Goal Weight & Eating Three Small
Meals Per Day
Month 2: Control Your Calories
Month 3: Think Healthily about Food, and Involve
Others in Your Weight Management Efforts
During the second three months of the study, the call
content and goals focus on the other topic (weight man-
agement or physical activity). However, participants may
also continue with goals they had previously been work-
ing toward during the first three months of the study.
In addition to the educational content provided, goal
setting and / or review (for physical activity and / or
weight management) is conducted during each telephone
call. During the first phone call, participants are guided
in the process of selecting a broad goal related to either
physical activity or weight management. While patients
are enabled to choose their own goals, the counselors
provide advisement about goals that are associated with
clinically relevant changes in health outcomes. With re-
gard to physical activity, we encourage participants to
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moderate intensity aerobic exercise per week, 2 sessions
of strengthening exercises per week, and stretching exer-
cises daily as a long-term goal. These recommendations
are based on U.S. physical activity guidelines [27]. How-
ever, counselors work with participants to determine rea-
sonable short-term goals based on their pain and
functional limitations. With regard to weight manage-
ment, NIH guidelines recommend that patients who are
overweight be encouraged to lose 10% of initial body
weight [29]. However, for some participants this may
seem like a difficult initial goal. Prior research has shown
that for adults with knee OA who are overweight, losing
even 5% of body weight can produce clinically relevant
improvements in pain and function [30]. Therefore the
counselors work with each participant to choose a rea-
sonable, individualized weight loss goal. Participants may
continue with any goal for as long as they choose, and
they may have more than one active goal.
During each phone call, participants are also guided in
the process of selecting specific action plans toward meeting
their goal(s). Action plans are written for each of the subse-
quent weeks between the current and next scheduled tele-
phone call. As a part of developing action plans, the
counselors ask participants to rate their self-efficacy for
completing each action plan on a scale of 1 to 10. If partici-
pants rate their self-efficacy lower than 7, the counselors
recommend they revise this plan so they are more confident
they will be able to carry it out. Prior research has shown
that a self-efficacy rating of 7 or above is associated with a
greater likelihood of accomplishing the plan [31]. The coun-
selors also ask participants about the action plans they have
been working on since the prior call, including any barriers
they encountered. The counselors guide participants in a
process of problem-solving any barriers, and this is incorpo-
rated into the process of developing new action plans.
Cognitive behavioral strategies are also discussed during
telephone calls according to the schedule shown in Table 1.
We have chosen to include this component throughout
the program because cognitive behavioral strategies (e.g.
cognitive restructuring) can be helpful for not only pain
control, but also for working toward behavioral goals such
as healthy eating and physical activity. The specific topics
included in the cognitive behavioral component of the
intervention are activity pacing, breathing relaxation, dis-
traction, progressive muscle relaxation, and cognitive re-
structuring. Each of these skills is discussed at two
telephone calls. The first call involves education about the
specific strategy (including a rationale for its application to
the management of OA-related pain), basic instruction in
the skill, and development of a plan for independent prac-
tice and application of the skill. During the second call for
each skill, the participant and counselor work collabora-
tively to review progress towards mastering, adapting, andapplying the skills to meet the participant’s individual
goals. Motivational interviewing strategies are employed
throughout the intervention to identify and address any
ambivalence participants exhibit regarding goals or apply-
ing new skills [32,33]. These strategies include asking open
ended questions, reflective listening, developing discrep-
ancy, rolling with resistance and eliciting change talk.
Written Patient Educational Materials We developed a
low-literacy patient educational booklet that covers the fol-
lowing topics: 1. What Is Osteoarthritis?, 2.) Physical Ac-
tivity and Osteoarthritis, 3. Weight Management, 4. Skills
for Managing Pain (Cognitive Behavioral Strategies).
Patients are asked to review these materials during the
intervention period. The booklet also includes worksheets
for documenting goals and action plans related to physical
activity and weight management, as well as worksheets for
documenting practice of cognitive behavioral skills.
Exercise Video Participants are given a copy of an exercise
video called Take Control with Exercise, created by the Arth-
ritis Foundation. Participants are also given therapy bands,
since these are used in some of the exercises on the video.
Relaxation CD Breathing relaxation and progressive
muscle relaxation are two skills covered in this interven-
tion. Participants are given CDs with audio instructions
to facilitate practice of these skills. These were developed
specifically for this study.
Provider intervention
The Provider Intervention involves delivery of patient-
specific recommendations, delivered at the point of care.
Specific recommendations include the following:
 Refer to physical therapist for evaluation and / or
therapeutic exercises
 Refer for evaluation for knee brace
 Refer to weight management program
 Refer to physical activity program
 Perform or refer for intra-articular injection
 Recommend or prescribe Topical NSAID or Capsaicin
 Add gastroprotective agent or remove from NSAID
(patient has risk factors for GI bleeding)
 Discuss discontinuation of OTC NSAID with patient
(patient has risk factors for GI bleeding)
 Discuss the possibility of trying a new / alternate
pain medication with patient
 Referral to orthopedic for evaluation for joint
replacement surgery (if no contraindications)
These recommendations were selected on the basis of
treatment guidelines for managing hip and knee OA
[12-14,34]. For most of these treatments, there are not
specific criteria (e.g., level of pain severity) to guide use.
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oped algorithms that guide when a treatment option
would be reasonable for a PCP to consider for a given pa-
tient. Algorithms are shown in Additional file 1. Data that
feed into these algorithms are derived from medical
records and baseline assessments (including both objective
measures and patient self-report measures). The study
team monitors upcoming visits for all participants enrolled
in the Provider Intervention, and recommendations are
delivered to PCPs within about one week prior to partici-
pants’ first routine (non-urgent) visit after enrolling in the
study. These recommendations are delivered to PCPs
within the electronic medical record systems. Within the
VA system, the study team provides PCPs with specific
instructions for requesting consults for some of the recom-
mendations, including knee braces (specific types); physical
therapy visits, referral to the MOVE! weight management
program, and orthopedic service visits for joint injections
and evaluation for surgery. For each Duke clinic, the study
team provides a list of local resources for physical activity
and weight management programs to which PCPs may
refer or direct patients.
Measures
Overview and timing
For both VA-based and Duke-based studies, the primary
time point for outcome assessment is 12-months following
baseline assessment. Baseline and 12-month assessments
are conducted in-person (except when transportation or
time constraints require completion of portions of the
questionnaire via telephone). We are also measuring the
primary outcome (and a few other selected outcomes) via
telephone at 6-months following baseline to examine the
time trajectory of changes during the study period. For the
Duke-based study, we will additionally evaluate the primary
and several other outcomes at 18-months and 24-months
following baseline, via telephone, to examine the sustain-
ability of any intervention effects observed at the 12-month
observation point.
Primary and secondary outcomes
The primary outcome measure for this study is the
WOMAC, a measure of lower extremity pain (5 items),
stiffness (2 items), and function (17 items). Secondary out-
comes are objective physical function and depressive symp-
toms, as these are both key outcomes for patients with OA
and are associated with pain. Objective physical function is
being assessed with the Short Physical Performance Test
Protocol [35], which is a series of five tests covering the
domains of balance (3 tests), gait speed (8-foot walk), and
time to rise from a chair and return to the seated position
five times. Depressive symptoms are being assessed with
the Patient Health Questionnaire (PHQ-8), a reliable and
valid measure of depression [36].Process / intermediate measures
Several process measures are being evaluated in order to
describe changes in intermediate outcomes that may be
associated with the interventions, either as mediating or
moderating factors. Process measures include the Arth-
ritis Self Efficacy [37], Self-Efficacy for Exercise scale
[38], Perceived Competence for Maintaining a Healthy
Diet [39], physical activity (Community Health Activities
Model Program for Seniors; CHAMPS) [40,41], dietary
intake using the Block Brief 2000 Food Frequency Ques-
tionnaire (3-Month Recall) [42], Pain Catastrophizing
Scale [43], Stone and Neale’s Daily Coping Inventory
adapted for pain coping [44], and the number of com-
pleted intervention calls (for those in the patient inter-
vention groups).
OA-related treatments and medical care
We are asking patients to report their use of OA-related
treatments, including: visits to physical therapists, visits to
orthopedic surgeons, receipt of joint injections, use of knee
braces, pain medication use, and topical analgesic use.
These data will allow us to evaluate whether there are any
differences in OA treatments (during the study period) be-
tween patients of providers / clinics who are in the Provider
intervention vs. Provider control arms.
Participant characteristics
We are collecting patient demographic and clinical charac-
teristics including: self-reported age, gender, race/ethnicity,
household financial situation, education level, marital status,
work status, health literacy (using the Rapid Estimate of
Adult Literacy -SF) [45], body mass index, history of knee
and hip injuries and surgeries, duration of OA symptoms,
general self-rated health, smoking, alcohol use, and comor-
bid illnesses using the Self-Administered Comorbidity
Questionnaire [46].
Exploratory measures
In addition, we are collecting exploratory measures that
are of interest in this patient population and type of inter-
vention. These measures include additional pain mea-
sures (visual analog and visual numeric scales [47,48],
measure of pain predictability from the Measure of Con-
stant and Intermittent Osteoarthritis Pain [49]), fatigue
visual analog scale [48], sleep quality (Insomnia Severity
Index [28] and Berlin Questionnaire [50]), foot symptoms
(Foot Assessment Clinical Tool [51]), Social Support for
Diet and Exercise [52], Satisfaction with Physical Func-
tion [53], and Global Assessment of Joint Symptom
Change (at follow-up only [54,55]). At follow-up we will
also assess perceptions of patients and providers about
the respective interventions, as well as suggestions for
improvements for future implementation, using open-
ended questions.
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For the VA-based study, we will enroll approximately 30
providers (15 per group) with 10 patients per provider (150
per group), for a total sample size of 300. Our goal was to
have sufficient sample size to detect a moderate effect size
of approximately 0.30 for the primary hypothesis with 80%
power and a type-I error rate (alpha) of 0.05. Based on
expected mean baseline WOMAC scores of 38 with a
standard deviation of 14 (anticipated from our prior pilot
work), this effect size translates to a 4.2 point difference at
12-months, which is equivalent to approximately 11% im-
provement from baseline scores. Sample size calculations
were based on methods appropriate for ANCOVA type
analyses [56] and adjusted for provider clustering using the
method of Donnar & Klar [57]. A correlation of 0.60 be-
tween time points was estimated based on our pilot data,
and we accounted for a 12% attrition rate. This yielded a
final sample size of 150 participants per group.
For the Duke-based study, we will enroll approximately
56 participants across each of 10 clinics, for a total sam-
ple size of 560. Our goal was to have sufficient sample
size to detect moderate effect size of approximately 0.39
for the primary hypotheses with 80% power and a type-I
error rate (alpha) of 0.05. Based on the same pilot data
described above, this effect size translates to a 5.5 point
difference at 12-months which is equivalent to approxi-
mately 15% improvement from baseline scores. For H1,
this implies that compared to usual care we can detect a
15% greater improvement in WOMAC scores for partici-
pants that receive the combined intervention than the
improvement in WOMAC scores for participants that
receive either the Patient or Provider only at 12-months.
For H2, this implies we can detect a 15% greater improve-
ment in those that receive either the Patient or Provider
intervention as compared to usual care at 12-months. Sam-
ple size calculations were based on methods appropriate for
ANCOVA type methods, [56] adjusted for clinic clustering
using the method of Donnar & Klar [57]. A correlation of
0.60 between time points was estimated based on our pilot
data, and we accounted for a 15% attrition rate. This yielded
a final sample size of 140 participants per group.
Data analyses
The main conclusions drawn from these trials will be based
on the pre-specified primary and secondary hypotheses and
will be tested with two-sided p-values at the standard 0.05
level. Primary analyses will be conducted on an intent-to-
treat basis; participants will be analyzed in the group to
which they were assigned, regardless of intervention adher-
ence, using all data up to the 12-months follow-up or last
available measurement prior to exclusion or dropout [58].
Statistical analyses will be performed using SAS for Win-
dows (Version 9.2: SAS Institute, Cary, NC) and R (http://
www.R-project.org).For the VA-based study, our primary hypothesis will be
tested using a hierarchical linear model with patients
nested within providers; baseline, 6- and 12-month values in
the response vector will be used to estimate changes in
WOMAC scores over time and test the primary hypothesis
[59]. A random effect will be included in the model to ac-
count for clustering of patients within providers, as the pro-
viders are the unit of randomization. Because of the small
number of time points, we will apply an unstructured co-
variance matrix to take into account the within-patient cor-
relation between repeated measures over time. The
predictors in the model will include a dummy coded time ef-
fect and an indicator variable for the intervention interacting
with the time effect. The fixed-effect portion of the model
will have the form [60]
Yijk ¼ β0 þ β1  time6ð Þ þ β2  time12ð Þ þ β3
 intervention  time6ð Þ þ β4
 intervention  time12ð Þ
We will estimate the parameters in the model using the
SAS procedure MIXED (Cary, NC). This method handles
dropout in a principled manner. However, depending on
the type and scope of any missing data, we will also explore
multiple imputation as a strategy to use in conjunction with
our primary analytic tools [61]. As recommended in the
Committee for Proprietary Medicinal Products guidelines,
the primary (as well as secondary) analyses will include the
race stratification variable as a fixed covariate in the main
analytic models. Secondary analyses will be conducted in a
similar manner, testing for differences in physical function
and depressive symptoms.
For the Duke-based study, our two primary hypotheses
will also be tested using a similar hierarchical linear model,
with patients nested within clinic. The predictors in this
model will include a dummy coded time effect and separate
indicator variables for the Provider and Patient interventions
interacting with the time effect. The fixed-effect portion of
the model will have the form
Yijk ¼ β0 þ β1  time6ð Þ þ β2  time12ð Þ
þβ3  provider  time6ð Þ þ β4  patient  time6ð Þ
þβ5  provider  patient  time6ð Þ
þβ6  provider  time12ð Þ
þβ7  patient  time12ð Þ
þβ8  provider  patient  time12ð Þ
for clinic i, patient j, at time k.
The specific test for H1 based on the above model
parameterization is testing that β8 equals zero. For H2, for
the Provider intervention alone compared to usual care at
12-months is a test of β6 equal 0 and for the Patient inter-
vention only it is β7 equal zero. The primary (as well as
secondary) analyses will include the race and gender strati-
fication variable as a fixed covariate in the main analytic
models. Secondary analyses will be conducted in a similar
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Economic evaluation
The objectives of the economic evaluation are to: 1) estimate
the cost per participant for each study group; 2) estimate the
annual OA-related healthcare utilization cost per participant
in each group; 3) estimate the effectiveness achieved by each
intervention; 4) estimate the incremental cost-effectiveness
of each intervention. The Patient intervention cost will con-
sist of labor costs (e.g., counselor training and telephone
calls) and equipment and materials costs. The incremental
cost incurred for the Provider intervention is primarily due
to the additional time needed to collect the information
from patients. Based on our prior experience with these
assessments, we estimate it will require 15 minutes of time.
In clinical practice, these measures would likely be obtained
by a nurse. The application of per-minute wage rates will be
used to derive this nurse cost.
We expect the interventions may affect two types of
healthcare utilization: outpatient visits (including both pri-
mary care and specialist visits for OA-related care) and
pain medication use. We will collect outpatient visit data
primarily from the VA’s Decision Support System adminis-
trative dataset and Duke University Medical Center billing
data. However, we will also ask patients to report office vis-
its outside of these healthcare systems in follow-up surveys.
For the VA –based study, pain medication use will also be
extracted from the Decision Support System. We will also
ask patients in both VA-based and Duke-based studies to
report their pain medication use. For standardization,
consistency, and to best approximate cost (rather than
charges or reimbursement), we will use Medicare reim-
bursement rates to monetize outpatient visits. Market
prices (e.g., from drugstore.com) will be applied to the
reported medications to derive medication cost.
We will use three effectiveness measures to calculate
cost effectiveness ratios: WOMAC units (primary out-
come), pain-free days (during the prior 30 days), and
quality-adjusted life years. The EuroQoL is used to con-
duct the utility measurements necessary to calculate
quality-adjusted life years [62]. Bivariate analyses will be
conducted to examine differences in costs and effective-
ness among the intervention arms. We will then calcu-
late the incremental cost effectiveness ratio (ICER) of the
intervention arms and control group relative to each
other. The ICER will be calculated as the difference in
the average cost per participant divided by the difference
in the average effectiveness per participant between
study group.
Timeline
Recruitment of participants began in August, 2011 and July,
2011 for VA-based and Duke -based studies, respectively.We expect that recruitment will be completed by Septem-
ber, 2012 and July, 2013, respectively.
Discussion
There are several important ways in which these studies will
advance our understanding of effective interventions to im-
prove OA outcomes. First, this is one of few studies to exam-
ine a provider-based intervention for hip and knee OA, and
to our knowledge it is the first to evaluate an intervention
that is feasible to disseminate broadly at relatively low cost
and resource use. This provider intervention is also novel be-
cause it involves patient-specific recommendations (e.g., not
only general information about OA treatment guidelines)
and is delivered at the point-of care. Second, although there
have been many studies of patient-based behavioral interven-
tions for hip and knee OA, to our knowledge this is the first
to combine comprehensive physical activity, weight manage-
ment, and cognitive behavioral pain management interven-
tions into a telephone-based program for patients with OA.
Because each of these behaviors has clinically relevant effects
on OA-related outcomes, through different mechanisms,
their combination may be stronger than any one or two of
these components alone. Third, these two studies provide an
opportunity to examine the interventions in two different
real-world clinical settings. Most prior studies of OA inter-
ventions have involved either community-based, self-referred
samples (which are likely a select sub-group) or patients at
academically-based medical centers (which can differ in
many ways from other primary care clinics). These studies
are being conducted in a VA medical center, which serves
many patients with complex medical needs, and in a group
of Duke community-based primary care clinics of diverse
sizes, organizational structures, locations (urban vs. rural),
and patient samples. At both sites, a population recruitment
strategy is employed rather than relying on self-referral.
These attributes will enhance generalizability of study find-
ings and provide an excellent picture of the feasibility and ef-
fectiveness of the interventions in a variety of clinical settings.
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